findmyKOL

Jessica Castilho, MD

Basic profile

Vanderbilt University Medical Center

ORCID↗NPI↗
✓ Full record
RegionNashville, TN · SoutheastSpecialtyInfectious DiseaseFocusInfectious Disease
Active KOLfindmyKOL type: RegionalLatest publication2025Online presenceNot yet checkedPaymentsNone reportedNIH funding2016–2026Why? →

Jessica Castilho is an Infectious Disease physician affiliated with Vanderbilt University Medical Center. OpenAlex indexes 81 publications with 1,871 citations (h-index 23).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
81publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,871citations

Total citations across indexed works.

23h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
4NIH grants · 2016–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

719 Thompson Ln
Suite 37189
Nashville, TN 372043609

Telephone

615-875-5111

Provider last certified this registry record 23 Mar 2022.

View the NPPES registry record

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    38.2%
    Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor12.7%
    Tivicay50%Dovato19%Isentress16%Juluca15%
    Part D<11 patients
    Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor11.4%
    Triumeq56%Descovy37%Abacavir-Lamivudine8%
    Part D<11 patients

    + 4 more classes in this area

  • Cardiovascular

    28.3%
    Statin10.7%
    Atorvastatin Calcium42%Pravastatin Sodium32%Rosuvastatin Calcium26%
    Part D<11 patients
    Calcium channel blocker3.7%
    Amlodipine Besylate69%Nifedipine Er31%
    Part D<11 patients

    + 7 more classes in this area

  • Metabolism & gastrointestinal

    13.8%
    Proton pump inhibitor7.3%
    Omeprazole71%Pantoprazole Sodium30%
    Part D<11 patients
    Biguanide (metformin)2.5%
    Metformin Hcl Er100%
    Part D<11 patients

    + 3 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

4 NIH research awards on record, funded 2016–2026 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”